Seattle Genetics Reports Fourth Quarter and Year 2013 Financial Results

[Business Wire] – Seattle Genetics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013. The company also highlighted ADCETRIS (brentuximab v more

View todays social media effects on SGEN

View the latest stocks trending across Twitter. Click to view dashboard

See who Seattle is hiring next, click here to view